Abstract:Abstract Background Newcastle disease virus (NDV) belongs to the genus Avaluvirus and Paramyxoviridae family, and it can cause acute, highly contagious Newcastle disease in poultry. The two proteins, haemagglutinin neuraminidase (HN) and Fusion (F), are the main virulence factor of the virus and play an essential role in immunogenicity against the virus. In most paramyxoviruses, the F protein requires HN protein to fuse the membrane, and HN proteins substantially enhance the viruses’ fusion activity. Results The present study describes the successful cloning and expression of HN protein from NDV in Bacillus subtilis WB800 using the modified shuttle vector pHT43. HN coding sequence was cloned into the pGet II vector. It was then subcloned into the PHT43 shuttle vector and transferred to Escherichia coli for replication. The recombinant plasmid was extracted from E. coli and used to transform B. subtilis by electroporation. After induction of recombinant B. subtilis by IPTG, total cell protein and the protein secreted into the media were analysed through a time course using SDS-PAGE. The expressed HN protein was purified using cation exchange chromatography followed by metal affinity chromatography, using the 6× His epitope introduced at the carboxyl terminus of the recombinant protein. The accuracy of the PHT43-HN construct was confirmed by sequencing and enzymatic digestion. SDS-PAGE results showed that the recombinant HN protein was successfully expressed and secreted into the medium. Moreover, the purified HN protein showed neuraminidase activity with characteristics similar to the indigenous HN NDV protein. B. subtilis is a free endotoxin host that could be a favourite prokaryotic platform for producing the recombinant HN protein. Conclusion The establishment of this expression and purification system has allowed us to explore further the biochemical characteristics of HN protein and obtain material that could be suitable for a new production of NDV candidate vaccine with high immunogenicity.

Prokaryotic expression of structural domains of the Newcastle disease virus fusion protein and analyses of their antigenic epitopes

Prokaryotic Expression of Structural Domains of the Newcastle Disease Virus Hemagglutinin-Neuraminidase

Expression of the Newcastle Disease Virus Fusion Glycoprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier

Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process.

Listeria Monocytogenes Mutants Carrying Newcastle Disease Virus F Gene Fused to Its Acta and Plcb: in Vitro Expression and Immunogenicity in Chickens.

Characterization of a Recombinant Listeria Monocytogenes Strain Containing the Fusion Protein Gene of Newcastle Disease Virus

Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus.

Expression and characterization of hemagglutinin–neuraminidase protein from Newcastle disease virus in Bacillus subtilis WB800

Expression of Vp2e and Vp3 Genes from Marine Birnavirus (MABV) in Insect Cells

'A'-Position-Mutated And G4-Mutated Hemagglutinin-Neuraminidase Proteins Of Newcastle Disease Virus Impair Fusion And Hemagglutinin-Neuraminidase-Fusion Interaction By Different Mechanisms

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

[Safety, Stability and Immunogenicity of an Oral DNA Vaccine Against Newcastle Disease].

Design and analysis of post-fusion 6-helix bundle of heptad repeat regions from Newcastle disease virus F protein.

Crystallization and preliminary X-ray diffraction analysis of post-fusion six-helix bundle core structure from Newcastle disease virus F protein.

Construction and Evaluation of the Immunogenicity and Protective Efficacy of Recombinant Replication-Deficient Human Adenovirus-5 Expressing Genotype VII Newcastle Disease Virus F Protein and Infectious Bursal Disease Virus VP2 Protein

Mutagenesis of the di-leucine motif in the cytoplasmic tail of newcastle disease virus fusion protein modulates the viral fusion ability and pathogenesis

A Plant-Produced Recombinant Fusion Protein-Based Newcastle Disease Subunit Vaccine and Rapid Differential Diagnosis Platform

Immobilization of Foreign Protein into BmNPV Polyhedra Through Fusion with Partial Polyhedrin Fragment

In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins